Clinical Trials Browser

Phase 2 × OTHER × Canvaxin × Clear all

NCT00004104 2016-03-31

Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma

Phase 2 Completed

Melanoma